VICTORINE NDEMATEBEM
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BLACKLICK, OH NPI 1548035637
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OH Acerta Pharma LLC All categories
General Payments — all program years on this page
$117.82
- Category: General Payments
- Program years: PY2024
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $117.82 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $117.82 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $30.43 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $29.10 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.61 | 1 |
| Novo Nordisk AS | $18.70 | 1 |
| GlaxoSmithKline, LLC. | $15.98 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $117.82 | 7 |
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086284188 | Bayer Healthcare Pharmaceuticals Inc. | $14.39 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086346319 | Bayer Healthcare Pharmaceuticals Inc. | $14.71 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100269814 | Novo Nordisk Inc | $18.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104291956 | AstraZeneca Pharmaceuticals LP | $14.99 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105635056 | AstraZeneca Pharmaceuticals LP | $15.44 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116138713 | GlaxoSmithKline, LLC. | $15.98 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144640786 | Xeris Pharmaceuticals, Inc. | $23.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.